Structural transition of various-sized sphere-platelet mixtures.

Monte Carlo simulations on the structural change of hard sphere-platelet mixtures were performed to investigate the effect of particle size. We quantitatively analyzed local equilibrium structures of sphere-platelet mixtures with varying size ratios under various sphere and platelet density conditions. Based on the simulation results, we investigated the structural transitions such as isotropic to anisotropic, clustering, and so on. When a small amount of small-sized sphere is added to a large-sized platelet system, the mixture structure transitions from isotropic to nematic ones as the platelet number density increases. On the other hand, the platelet forms clusters with the addition of a large number of spheres. In a small platelet-large sphere system, the spheres form aggregates by increasing platelet density instead. The platelet and spherical particles exhibit different structural transitions depending on the size and density. In the limit of small and large size ratios, the structures of the platelet-sphere mixture obtained from the Monte Carlo simulation are close to those shown by previous theoretical and experimental studies, respectively. Because the primary actor shifts from sphere to platelet as the size ratio changes, the transition boundary shifts continuously. When the size ratio is close to unity, the most complicated behavior is observed, with both the platelet and sphere simultaneously acting the leading part.

Rice Bran Supplement Containing A Functional Substance, the Novel Peptide Leu-Arg-Ala, has Anti-Hypertensive Effects: A Double-Blind, Randomized, Placebo-Controlled Study.

The anti-hypertensive effect of processed rice bran (PRB) was recently reported, for which the novel peptide Leu-Arg-Ala (LRA) was identified as the functional substance. The purpose of this study was to assess the anti-hypertensive effects of a rice bran supplement containing PRB in individuals with high-normal blood pressure (systolic blood pressure (SBP): 130⁻139 mmHg and/or diastolic blood pressure (DBP): 85⁻89 mmHg) or grade 1 hypertension (SBP: 140⁻159 mmHg and/or DBP: 90⁻99 mmHg). One hundred individuals with high-normal blood pressure or grade 1 hypertension were recruited to participate in this double-blind, randomized, placebo-controlled study. Participants were randomly allocated to the placebo group (n = 50) or the test group (n = 50). Each group took four test tablets (43 µg LRA/day) or four placebo tablets daily. The decrease in blood pressure in the test group compared with the placebo group was the primary outcome. Adverse events were recorded and hematological/urinary parameters measured to determine the safety of the supplement, which was the secondary outcome. In total, 87 participants completed the study. The SBP of the test group at 12 weeks was significantly lower than that of the placebo group (p = 0.0497). No serious adverse events were observed. Daily consumption of a rice bran supplement containing PRB can safely improve mildly elevated blood pressure.

Nanoscale observations of magnesite growth in chloride- and sulfate-rich solutions.

Magnesite growth in chloride and sulfate-rich solutions has been examined at 90 °C in situ using phase-shift interferometry (PSI) and ex situ using atomic force microscopy (AFM) to evaluate the feasibility of cosequestering SO2 and CO2 in Mg-rich rocks. Although sulfate may assist desolvation at the magnesite surface, evidence for enhanced growth was only found at specific surface sites. The overall growth rates fit with those observed for chloride experiments in similarly saturated solutions. Thus, the formation of Mg-SO4 ion pairs in solution, which lowers the supersaturation with respect to magnesite, will have the dominant effect during sequestration. Lowering the activity of Mg(2+) ions in solution also inhibited the nucleation of other hydrated Mg-carbonate phases. As no evidence was found for sulfate incorporation into the growing magnesite, the presence of sulfate in solution will be detrimental to CO2 sequestration and is not expected to be cosequestered. The PSI data also emphasize the variability of reactivity over the surface and how this changes as a function of solution saturation and composition.

Magnetite 3D colloidal crystals formed in the early solar system 4.6 billion years ago.

Three-dimensional colloidal crystals made of ferromagnetic particles, such as magnetite (Fe(3)O(4)), cannot be synthesized in principle because of the strong attractive magnetic interaction. However, we discovered colloidal crystals composed of polyhedral magnetite nanocrystallites of uniform size in the range of a few hundred nanometers in the Tagish Lake meteorite. Those colloidal crystals were formed 4.6 billion years ago and thus are much older than natural colloidal crystals on earth, such as opals, which formed about 100 million years ago. We found that the size of each individual magnetite particle determines its morphology, which in turn plays an important role in deciding the packing structure of the colloidal crystals. We also hypothesize that each particle has a flux-closed magnetic domain structure, which reduces the interparticle magnetic force significantly.

Real-time optical system for observing crystallization in levitated silicate melt droplets.

In this study, a real-time optical system was developed to observe crystallization in a small spherical melt droplet (few millimeters in diameter) by containerless processing. This system can be used to simultaneously observe the inside and the surface of a transparent melt droplet, as well as its ambient gas atmosphere at high temperatures. A silicate melt with a diameter of approximately 2 mm and a composition of MgO:SiO(2)=48:52 was levitated using a gas-jet levitation system, and its crystallization process was successfully observed from 2385 K in real time with good contrast using the developed optical setup.

Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.

PURPOSE: Laser speckle flowgraphy (LSFG) can be used to non-invasively visualize the haemodynamics of choroidal circulation and the vascular pattern. The purpose of this study was to examine the ability of LSFG to quantitatively evaluate blood flow velocity at the macula in patients with Vogt-Koyanagi-Harada (VKH) disease before and after systemic corticosteroid therapy. METHODS: Prednisolone (200 mg/day) was systemically administered in 10 VKH disease patients with serous retinal detachment at the macular area. The drug was gradually tapered to zero over a 6-month period. Laser speckle flowgraphy measurements were taken in the 20 eyes of these patients at their initial visit and at 1, 4 and 12 weeks after the onset of therapy. Square blur rate (SBR), a quantitative index of relative blood flow velocity, was calculated using LSFG. RESULTS: Serous retinal detachment resolved within 4 weeks after treatment and visual acuities improved to > 1.0 in almost all cases. There were significant increases in average SBR at the macula at 4 weeks after treatment compared with at 1 week after treatment, and also at 12 weeks after treatment compared with at 4 weeks after treatment. CONCLUSIONS: These results suggest that systemic corticosteroid therapy improves inflammation-related impairment in choroidal blood flow velocity at the macula. Laser speckle flowgraphy can evaluate the effect of systemic corticosteroid therapy by enabling comparisons between measurements of blood flow velocity, which is considered to reflect inflammation activity in the choroid.